She has a diverse range of expertise in magnetic resonance spectroscopy (MRS), PET chemistry, cancer biology, and pharmacology. She was trained in in vivo MRS within the MRI division and in molecular oncology within Hematology division at John Hopkins University, Baltimore, USA. Her research focus is on the development of drugs and PET imaging tracers targeting the CXCR4 chemokine receptor that plays critical part in cancer metastasis. In addition, she is an Executive Committee member of NCI Quantitative Imaging Network (QIN).